FX.co ★ Lexicon Appoints Scott Coiante As CFO, SVP

Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical firm, has announced the appointment of Scott Coiante to the position of Chief Financial Officer and Senior Vice President, effective January 2. Coiante brings 35 years of expertise in the science and pharmaceutical sectors, previously holding the roles of Senior Vice President, Chief Financial Officer, and Treasurer at Agile Therapeutics. Notably, on Tuesday, LXRX shares finished at $0.73, marking a 2.63% increase on the Nasdaq.